In our immunohistochemical analysis of malignant and benign prostate tissue, we revealed an increased expression of CYP7B1 in men with prostate cancer and an association between an increased risk of biochemical recurrence in a subgroup analysis of men without diabetes. This evidence concerns the gene CYP7B1 and prostate cancer.